Cellosaurus 306D326.26 (CVCL_B0UY)
Cell line name | 306D326.26 |
---|---|
Synonyms | LT1002; Sphingomab |
Accession | CVCL_B0UY |
Resource Identification Initiative | To cite this cell line use: 306D326.26 (RRID:CVCL_B0UY) |
Comments | Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized sonepcizumab (LT1009; Asonex) therapeutic antibody candidate for treatment of patients with cancer or ocular diseases. Monoclonal antibody isotype: IgG1, kappa. Monoclonal antibody target: ChEBI; CHEBI_37550; Sphingosine 1-phosphate (S1P). |
Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) |
Category | Hybridoma |
Publications | PubMed=19509417; DOI=10.1194/jlr.M900048-JLR200; PMCID=PMC2759830 Patent=US9163091 |
Cross-references | |
Cell line collections (Providers) | ATCC; SD-5362 - Discontinued |
Encyclopedic resources | Wikidata; Q108819537 |
Entry history | |
Entry creation | 23-Sep-2021 |
Last entry update | 19-Dec-2024 |
Version number | 6 |